These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24025490)

  • 21. Cellular and synaptic network defects in autism.
    Peça J; Feng G
    Curr Opin Neurobiol; 2012 Oct; 22(5):866-72. PubMed ID: 22440525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain and behavior in fragile x syndrome and idiopathic autism.
    Harris JC
    Arch Gen Psychiatry; 2011 Mar; 68(3):230-1. PubMed ID: 21383260
    [No Abstract]   [Full Text] [Related]  

  • 23. Biochemical and biological characterization of tumor-associated mutations of p110alpha.
    Denley A; Gymnopoulos M; Hart JR; Jiang H; Zhao L; Vogt PK
    Methods Enzymol; 2008; 438():291-305. PubMed ID: 18413256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunct diagnostic test for Angelman syndrome: the tuning fork response.
    Hall BD
    Am J Med Genet; 2002 May; 109(3):238-40. PubMed ID: 11977186
    [No Abstract]   [Full Text] [Related]  

  • 25. Forebrain depletion of Rheb GTPase elicits spatial memory deficits in mice.
    Shahani N; Huang WC; Varnum M; Page DT; Subramaniam S
    Neurobiol Aging; 2017 Feb; 50():134-143. PubMed ID: 27960107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug development targeting synaptic molecules - autism mouse models as an example].
    Sakurai T
    Nihon Yakurigaku Zasshi; 2013 Sep; 142(3):116-21. PubMed ID: 24025492
    [No Abstract]   [Full Text] [Related]  

  • 27. [Synaptic development and abnormality at protein level].
    Shirao T; Sekino Y; Takahashi H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Aug; 24(4):247-56. PubMed ID: 15484828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins.
    Zhang Y; Gao X; Saucedo LJ; Ru B; Edgar BA; Pan D
    Nat Cell Biol; 2003 Jun; 5(6):578-81. PubMed ID: 12771962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anterior to posterior limb of the internal capsule morphology in fragile X syndrome.
    Fahim C; Meguid N; Evans AC
    Dev Med Child Neurol; 2009 Oct; 51(10):839-40. PubMed ID: 19747282
    [No Abstract]   [Full Text] [Related]  

  • 30. The mGluR theory of fragile X mental retardation.
    Bear MF; Huber KM; Warren ST
    Trends Neurosci; 2004 Jul; 27(7):370-7. PubMed ID: 15219735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rapamycin].
    Yonezawa K
    Nihon Rinsho; 2005 May; 63 Suppl 5():718-22. PubMed ID: 15954435
    [No Abstract]   [Full Text] [Related]  

  • 32. Angelman syndrome at the synapse: meeting report of the Angelman Syndrome Foundation's 2009 scientific symposium.
    Williams C; Franco L
    J Child Neurol; 2010 Feb; 25(2):254-61. PubMed ID: 20101047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synaptic dysfunction and disruption of postsynaptic drebrin-actin complex: a study of neurological disorders accompanied by cognitive deficits.
    Kojima N; Shirao T
    Neurosci Res; 2007 May; 58(1):1-5. PubMed ID: 17379343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral aspects of epilepsy in children with mental retardation.
    Caplan R; Austin JK
    Ment Retard Dev Disabil Res Rev; 2000; 6(4):293-9. PubMed ID: 11107194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A decade of molecular studies of fragile X syndrome.
    O'Donnell WT; Warren ST
    Annu Rev Neurosci; 2002; 25():315-38. PubMed ID: 12052912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic mRNA targeting and translation.
    Kindler S; Kreienkamp HJ
    Adv Exp Med Biol; 2012; 970():285-305. PubMed ID: 22351061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the Nogo-A system in cortical lesions of pediatric patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Yu SX; Li S; Shu HF; Zhang CQ; Liu SY; Yang H
    J Neuropathol Exp Neurol; 2012 Jul; 71(7):665-77. PubMed ID: 22710967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the postsynaptic density in the pathology of the fragile X syndrome.
    Kindler S; Kreienkamp HJ
    Results Probl Cell Differ; 2012; 54():61-80. PubMed ID: 22009348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synaptic regulation of protein synthesis and the fragile X protein.
    Greenough WT; Klintsova AY; Irwin SA; Galvez R; Bates KE; Weiler IJ
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7101-6. PubMed ID: 11416194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasticity of nonneuronal brain tissue: roles in developmental disorders.
    Dong WK; Greenough WT
    Ment Retard Dev Disabil Res Rev; 2004; 10(2):85-90. PubMed ID: 15362161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.